I am currently vacationing in Dana Point California. The local residents are complaining about the unprecedented heat but we are very grateful for the 80° temperatures even if the humidity is around 30%. The ocean breezes are so pleasant and you can actually sit outside in the shade!
I have been reviewing worldwide scientific evidence, to date, available on breast cryotherapy and the body's subsequent immune response in advanced breast cancers as I have had several requests from patients across the country seeking cryotherapy for their stage III and IV breast cancers.
As you know we have performed 19 successful cryotherapies on stage1, low-grade invasive breast cancers since April 2016.
I am excited to report to you there is an abundance of pooled scientific data from around the world on patients’ immune response to their breast cancer following cryotherapy.
We have known for years our bodies can develop cancer cells but these cancerous cells do not ever become a clinical cancer as the body's immune system recognizes this cancer cell and quickly kills it. If the cancer cell divides and the cancer enlarges and acquires a blood flow it can overwhelm the immune response and even worse spread to distant organs such as the liver, brain and lungs which leads to failure of those vital organs and death.
It is now well documented that radiation therapy of cancer stimulates the immune reaction of the patient to that cancer which is why it is often additionally beneficial after lumpectomy for breast cancer. Cryotherapy also stimulates the immune response because it acts like a vaccination making the cancer cells more recognizable to the immune system. In mice, in many cases, it was even more stimulatory to the immune system than radiation therapy without the side effects. The most exciting development is that once the immune system mounts a defense against the cancer in the breast it has been documented that cancers that have spread to other organs also start decreasing in size and sometimes disappear completely. This is called the abscopal effect.
Stage III and IV breast cancers have usually already undergone surgery, radiation and often chemotherapy and anti-estrogen therapy but have still spread to vital organs. Typically patients are told there are no further treatment options. Stimulating the immune response of the patient with cryotherapy and known immune modulators may offer alternative therapy and relief of symptoms. These patients often go to alternative clinics outside of the United States where there are many reports of miracle cures that can now be explained by the stimulation of their own immune systems.
Having educated myself about these new therapies I will now cautiously proceed to explore cryotherapy and immune therapy in advanced breast cancer cases as many colleagues across the country are currently doing.